Global Mucopolysaccharidosis (MPS) Treatment Industry Set to Reach US$ 3.37 Billion by 2029, Reports
The Global Mucopolysaccharidosis (MPS) Treatment Industry is poised for significant growth, with a projected valuation of US$ 3.37 billion by 2029, as stated in a comprehensive market study presented by Future Market Insights (FMI). In 2022, the market is estimated to be worth approximately US$2.38 billion, showcasi...
Source: pharmiweb.com